Bausch Health Companies BHC
NYSE BHC
$6.16 -0.26 (-4.12%)
As of: Sep 9, 2026 · 3:59 PM EDT

Bausch Health Companies (BHC) Gross Margin (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Gross Margin came in at 73.6% in Q2 2026, up 316.0% year-over-year from 17.69% in Q2 2025, and up 3.03% quarter-over-quarter from 71.43% in Q1 2026.

Analysis

Bausch Health Companies (BHC) Gross Margin (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Gross Margin across 18 years of filings, most recently posting 73.6% for Q2 2026.

  • In Q2 2026, Gross Margin rose 316.0% year-over-year to 73.6%; the TTM figure through Jun 2026 stood at 72.43% (up 108.0% YoY), while the FY2025 annual figure was 71.27%, down 37.0% from the prior year.
  • Gross Margin came in at 73.6% for Q2 2026 at Bausch Health Companies, up from 71.43% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 73.6% in Q2 2026 to a low of 69.77% in Q1 2025.
  • Average Gross Margin over 5 years is 71.51%, with a median of 71.29% recorded in 2026.
  • Year-over-year, Gross Margin sank 148 bps in 2023 and surged 316 bps in 2026.
  • Over 5 years, Gross Margin stood at 70.86% in 2022, then gained by 0 bps to 71.14% in 2023, then gained by 2 bps to 72.22% in 2024, then fell by 0 bps to 72.0% in 2025, then rose by 2 bps to 73.6% in 2026.
  • Per Business Quant data, the three most recent Gross Margin figures were 73.6% in Q2 2026, 71.43% in Q1 2026, and 72.0% in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 51.98%
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 38.77%
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 46.52%
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 42.01%
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 73.60%
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 4.68%
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 62.35%
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 50.83%
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn 95.97%
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 73.60%
Mar 31, 2026 71.43%
Dec 31, 2025 72.00%
Sep 30, 2025 72.58%
Jun 30, 2025 70.43%
Mar 31, 2025 69.77%
Dec 31, 2024 72.22%
Sep 30, 2024 72.83%
Jun 30, 2024 70.54%
Mar 31, 2024 70.83%
Dec 31, 2023 71.14%
Sep 30, 2023 72.65%
Jun 30, 2023 70.47%
Mar 31, 2023 70.58%
Dec 31, 2022 70.86%
Sep 30, 2022 71.99%
Jun 30, 2022 71.12%
Mar 31, 2022 72.05%
Dec 31, 2021 72.31%
Sep 30, 2021 72.81%